To elucidate the role of PTN receptors in RRMS, we first analyzed PBMCs from a subgroup of RRMS patients treated with IFN-β (n = 33) and compared them with HCS (n = 42) using RT-qPCR. Here, IFNB1 is linked to relapsing-remitting multiple sclerosis.